-
STEMart has announced the launch of its Disinfection Efficacy Studies Services in various standards to ensure the safety of medical devices.
Oct 31, 2023
-
Creative Diagnostics has launched a range of antibodies, antigens and kits against CLDN6 to support researchers.
Oct 31, 2023
-
CD BioSciences has announced the launch of its 3D Image Analysis Services for researchers.
Oct 31, 2023
-
Oct 15, 2023
-
Oct 29, 2023
-
Oct 4, 2023
-
BioIVT will be available to discuss its newly expanded, comprehensive portfolio of neuro-related disease and TruNormal® biospecimens at Neuroscience 2023.
Oct 26, 2023
-
Fapon entered into a strategic cooperation agreement with two Swiss biotech companies LASCCO SA and Abionic SA, that granted Fapon an exclusive license to utilize the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China. This strategic partnership will enable Fapon to engage in the research, development, manufacturing, and commercialization of PSP raw materials and chemiluminescent immunoassay (CLIA)-based reagent solutions within the Chinese market.
Oct 26, 2023
-
Oct 25, 2023
-
Oct 25, 2023
-
Compliance with global information security management standard strengthens customer trust
Oct 23, 2023
-
Oct 23, 2023
-
Oct 23, 2023
-
Oct 23, 2023
-
Oct 23, 2023
-
Oct 23, 2023
-
Creative Biolabs, a prominent provider of groundbreaking biotechnology solutions, proudly announced the expansion of its antibody-drug conjugate (ADC) business with the introduction of novel services.
Oct 22, 2023
-
Oct 22, 2023
-
Oct 8, 2023
-
Oct 18, 2023